CIK: 1563584 - Address: C/o Intellia Therapeutics, Inc., 40 Erie Street; Suite 130, Cambridge, MA 02139
49 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret112312148-33-27-4
P%wins1001005050505067
S%ret2131334184412
S%wins67033330022

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/5/24 16:51
1/3/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS-56629.460-19-2905D
1/3/24 17:30
1/1/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d00.00081924D
1/6/23 17:32
1/4/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS-24837.210-7-1825D
1/4/23 20:36
1/1/23
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d00.00081832D
3/4/22 21:07
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d00.00081824D
3/4/22 21:07
1/1/22
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-280112.260-20824D
9/1/21 20:21
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.dm2,07117.06012118778D
9/1/21 20:21
8/30/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.dm-19,520160.830-121-13778D
8/25/21 16:14
8/23/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d36413.400274778D
8/25/21 16:14
8/23/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-4,125152.010-27-3778D
8/20/21 18:14
8/19/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d30413.400233778D
8/20/21 18:14
8/19/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-3,431151.280-23-3778D
4/15/21 20:50
4/13/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d29011.160263778D
4/2/21 20:46
4/1/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d1,00514.1507110752D
4/2/21 20:46
4/1/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-3,19683.640-38-5752D
2/9/21 20:36
2/5/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.dm9239.5509716719D
2/9/21 20:36
2/5/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.dm-3,65571.700-51-7719D
2/3/21 21:39
2/1/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.dm4,80715.16031789673D
2/3/21 21:39
2/1/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.dm-11,95567.260-178-21673D
1/5/21 21:24
12/31/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d00.000143534D
1/5/21 21:24
1/5/21
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-34955.860-6-1534D
11/27/20 21:00
11/27/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d56616.170357526D
11/27/20 21:00
11/27/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-1,35038.570-35-6526D
11/25/20 20:02
11/25/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d3426.8305011526D
11/25/20 20:02
11/25/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-1,80036.000-50-9526D
11/18/20 19:56
11/16/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d29214.580204526D
11/18/20 19:56
11/16/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-68034.000-20-4526D
11/6/20 16:38
11/4/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d3426.8305011526D
11/6/20 16:38
11/4/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-1,30026.000-50-9526D
10/9/20 16:14
10/7/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOM.d346.83051526D
10/9/20 16:14
10/7/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEOS.d-10921.830-5-1526D
9/3/20 16:15
9/1/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOM.d346.83051526D
9/3/20 16:15
9/1/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOS.d-10921.830-5-1526D
8/7/20 19:29
8/6/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOM.d346.83051526D
8/7/20 19:29
8/6/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOS.d-10921.830-5-1526D
7/2/20 16:10
7/1/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOM.d346.83051526D
7/2/20 16:10
7/1/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOS.d-10921.830-5-1526D
6/5/20 17:18
6/3/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOM.d346.83051526D
6/5/20 17:18
6/3/20
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOS.d-10921.830-5-1526D
12/26/19 16:33
12/20/19
IQVIqvia Holdings Inc.NCHealthBiolabCommercial Physical & BiologiLeonard John M.CTDM.d1,30864.770208D
12/26/19 16:33
12/20/19
IQVIqvia Holdings Inc.NCHealthBiolabCommercial Physical & BiologiLeonard John M.CTDS.d-3,091153.000-20-718D
5/15/18 20:43
5/14/18
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John M.MADOP,CEOS-20224.000-8-2526I
9/16/16 18:46
9/15/16
CMRXChimerix IncDEHealthDrugPharmaceutical PreparationsLeonard John M.NCDS-255.033-5-1000I-80-8933525166804-20-2011
8/25/15 14:25
8/21/15
CMRXChimerix IncDEHealthDrugPharmaceutical PreparationsLeonard John M.NCDP4747.38201255I1508896-7-20-12-1239-1-9-89-89
11/6/14 16:50
11/5/14
CMRXChimerix IncDEHealthDrugPharmaceutical PreparationsLeonard John M.NCDP11629.00334New4D9680262-18-9-631428252336
3/19/13 17:13
3/15/13
ABBVAbbvie Inc.DEHealthDrugPharmaceutical PreparationsLeonard John M.ILOSVP,ChieM.d1,34828.86334770114D23232311132244
3/19/13 17:13
3/15/13
ABBVAbbvie Inc.DEHealthDrugPharmaceutical PreparationsLeonard John M.ILOSVP,ChieS.d-1,79638.4533-47-29114D23232311132244
3/12/13 17:08
3/8/13
ABBVAbbvie Inc.DEHealthDrugPharmaceutical PreparationsLeonard John M.ILOSVP,ChieS-1,04837.5133-28-20114D2-1200317192144
2/21/13 17:04
2/19/13
ABBVAbbvie Inc.DEHealthDrugPharmaceutical PreparationsLeonard John M.ILOSVP,ChieM.d80927.29333024155D16576-1-5-1211339

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact